Serum alarmin S100A8/S100A9 levels and its potential role as biomarker in myocarditis

AIMS: The alarmin S100A8/S100A9 (S100A8/A9) is released by activated monocytes/macrophages and neutrophils in the setting lymphocytic myocarditis (MC). We recently demonstrated its therapeutic potential in experimental acute MC. Now, we investigated the diagnostic relevance of S100A8/A9 serum levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Irene, Vogl, Thomas, Kühl, Uwe, Krannich, Alexander, Banks, Aron, Trippel, Tobias, Noutsias, Michel, Maisel, Alan S., van Linthout, Sophie, Tschöpe, Carsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373886/
https://www.ncbi.nlm.nih.gov/pubmed/32462801
http://dx.doi.org/10.1002/ehf2.12760

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373886/
https://www.ncbi.nlm.nih.gov/pubmed/32462801
http://dx.doi.org/10.1002/ehf2.12760

Ejemplares similares